MenQuadfi
meningococcal group A, C, W-135 and Y conjugate vaccine
Meningitis, Meningococcal
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
Nimenrix
meningococcal groups A, C, W-135 and Y conjugate vaccine
Meningitis, Meningococcal
Date of authorisation:
Revision: 36
Last updated:
MedicineHumanAuthorised
EMEA-001930-PIP01-16-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0222/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000429-PIP01-08-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0089/2015
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
BroPair Spiromax
salmeterol
fluticasone propionate
Asthma
Date of authorisation:
Revision: 1
Last updated:
MedicineHumanAuthorised
Seffalair Spiromax
salmeterol
fluticasone propionate
Asthma
Date of authorisation:
Last updated:
MedicineHumanAuthorised
Aerivio Spiromax
salmeterol
fluticasone propionate
Pulmonary Disease, Chronic Obstructive
Asthma
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanWithdrawn
Airexar Spiromax
salmeterol xinafoate
fluticasone propionate
Pulmonary Disease, Chronic Obstructive
Asthma
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanWithdrawn
EMEA-002177-PIP01-17 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Pneumology-allergology
PIP number: P/0245/2017
Route(s) of administration: Inhalation use
Pharmaceutical form(s):
Inhalation powder
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Budesonide / salmeterol xinafoate - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Pneumology-allergology
PIP number: P/47/2010
Route(s) of administration: Inhalation use
Pharmaceutical form(s):
Inhalation powder
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman